Mirabaud Asset Management Ltd Decreases Stock Position in The Clorox Company $CLX

Mirabaud Asset Management Ltd lessened its stake in shares of The Clorox Company (NYSE:CLX) by 61.3% in the 2nd quarter, Holdings Channel reports. The firm owned 5,511 shares of the company’s stock after selling 8,742 shares during the period. Mirabaud Asset Management Ltd’s holdings in Clorox were worth $657,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. bought a new position in Clorox during the second quarter valued at approximately $202,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Clorox by 9.3% in the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 267,755 shares of the company’s stock worth $32,149,000 after acquiring an additional 22,790 shares during the last quarter. Parkside Financial Bank & Trust raised its holdings in shares of Clorox by 959.1% during the 2nd quarter. Parkside Financial Bank & Trust now owns 2,690 shares of the company’s stock worth $323,000 after acquiring an additional 2,436 shares in the last quarter. Aviva PLC raised its holdings in shares of Clorox by 5.0% during the 2nd quarter. Aviva PLC now owns 92,203 shares of the company’s stock worth $11,071,000 after acquiring an additional 4,396 shares in the last quarter. Finally, Prospera Financial Services Inc boosted its position in shares of Clorox by 22.0% during the 2nd quarter. Prospera Financial Services Inc now owns 5,522 shares of the company’s stock valued at $664,000 after acquiring an additional 994 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Clorox Trading Up 1.0%

Shares of CLX opened at $107.37 on Friday. The company’s fifty day simple moving average is $119.49 and its 200-day simple moving average is $124.82. The company has a market cap of $13.10 billion, a P/E ratio of 16.47, a P/E/G ratio of 0.92 and a beta of 0.52. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The Clorox Company has a twelve month low of $106.14 and a twelve month high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.41 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm’s revenue for the quarter was down 18.9% compared to the same quarter last year. During the same period in the previous year, the company earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were paid a dividend of $1.24 per share. The ex-dividend date of this dividend was Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.6%. Clorox’s dividend payout ratio is currently 77.86%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on CLX shares. Bank of America reduced their price target on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. UBS Group set a $119.00 price objective on shares of Clorox and gave the stock a “neutral” rating in a research note on Tuesday. Citigroup reduced their target price on shares of Clorox from $130.00 to $120.00 and set a “neutral” rating on the stock in a report on Tuesday, November 4th. JPMorgan Chase & Co. decreased their target price on shares of Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 4th. Finally, Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 28th. One equities research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and an average target price of $125.69.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.